Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction RELY-II

Journal of the Canadian Urological Association

Volumn 2, Issue 3, 2008, Pages 187-195

  Valiquette, Luc ^a   Montorsi, Francesco ^b   Auerbach, Stephen ^c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c Vardenafil Study Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62649122750     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.590     Document Type: Article

References (30)

1. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000;12(Suppl 4):S6-11.
2. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
3. Fisher WA, Meryn S, Sand M, et al. Communication about erectile dysfunction among men with ED, partners of men with ED, and physicians: The Strike Up a Conversation Study (Part 1). J Men Health Gender 2005;2:64-78. (Pubitemid 41095294)
4. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002;39:283-303.
5. Nicolosi A, Moreira ED Jr, Villa M, et al. A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men. J Affect Disord 2004;82:235-243
6. Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction is a marker for cardiovascular disease: Results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005;2:40-50.
7. Lochmann A, Gallmetzer J. Erectile dysfunction of arterial origin as possible primary manifestation of atherosclerosis. Minerva Cardioangiol 1996;44:243-246
8. Morley JE, Korenman SG, Kaiser FE, et al. Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med 1988;84:445-448
9. Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004;171:2341-2345
10. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151: 54-61.
11. Doumas M, Tsakiris A, Douma S, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared to normotensive subjects. J Androl 2006;27:469-477
12. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294:2996-3002.
13. Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997;9:123-126
14. O'Leary MP, Fowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology. Urology 1995;46:697-706.
15. Goldman L, Hashimoto B, Cook E, et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981;64:1227-1234
16. Eardley I, Rosen R, Fisher WA, et al. What men want: desired attributes of ED therapy among men with ED in the MALES 2004 study. J Sex Med 2004;42(Suppl 1):Abstract O44.
17. Kwok YS, Kim C. Valuing Viagra: what is restoring potency worth? Eff Clin Pract 1999;2:171-175
18. American Urological Association. Management of Erectile Dysfunction ('05 Updated '06). Available: www.auanet.org/guidelines/edmgmt.cfm (accessed 2007 Jan 17).
19. Meuleman EJ, Eardley I, Rosen R, et al. Attitudes toward treatment of erectile dysfunction: results from the MALES (Men's Attitudes toward Life Events and Sexuality) study. Presented at the Annual Meeting of the Asian Pacific Society of Sexual and Impotence Research, Cebu, Philippines, 2003 Oct.1-4.
20. Eardley I, Rosen R, Fisher WA, et al. Attitudes toward treatment of erectile dysfunction: results from the MALES study [Abstract 377]. Eur Urol Suppl 2003;2:97.
21. Valiquette L, Young JM, Moncada I, et al.; Vardenafil Study Group. Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, doubleblind, placebo-controlled study. Mayo Clin Proc 2005;80:1291-1297
22. Valiquette L, Montorsi F, Auerbach S; Vardenafil Study Group. First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I. Int J Clin Pract 2006;60:1378-1385
23. Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001;13:192-199
24. Porst H, Young JM, Schmidt AC, et al.; International Vardenafil Study Group. Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. Urology 2003;62:519-23; discussion 523-524. (Pubitemid 36999881)
25. Stief C, Porst H, Saenz De Tejada I, et al.; Vardenafil Study Group. Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract 2004;58:230-239
26. Sheu JY, Chen KK, Lin AT, et al. Long-term efficacy and safety of sildenafil for patients with erectile dysfunction. J Chin Med Assoc 2003;66:480-486
27. Carson CC, Hatzichristou D, Carrier S, et al. Vardenafil exhibits efficacy in men with erectile dysfunction unresponsive to prior sildenafil therapy: results of a phase-III clinical trial - patient response with vardenafil in sildenafil nonresponders (PROVEN). Int J Impot Res 2003;15(Suppl 5):S175.
28. Montorsi F, Hellstrom WJ, Valiquette L, et al. North American and European Vardenafil Groups. Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology 2004;64:1187-1195
29. McCullough AR, Barada JH, Fawzy A, et al. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology 2002;60(Suppl 2):28-38.
30. Schulman CC, Shen W, Stothard DR, et al. Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction. Urology 2004;64:783-788